1. Home
  2. FLGC vs NEPH Comparison

FLGC vs NEPH Comparison

Compare FLGC & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FLGC
  • NEPH
  • Stock Information
  • Founded
  • FLGC 2019
  • NEPH 1997
  • Country
  • FLGC United States
  • NEPH United States
  • Employees
  • FLGC N/A
  • NEPH N/A
  • Industry
  • FLGC Biotechnology: Pharmaceutical Preparations
  • NEPH Medical/Dental Instruments
  • Sector
  • FLGC Health Care
  • NEPH Health Care
  • Exchange
  • FLGC Nasdaq
  • NEPH Nasdaq
  • Market Cap
  • FLGC 17.3M
  • NEPH 16.8M
  • IPO Year
  • FLGC 2021
  • NEPH 2004
  • Fundamental
  • Price
  • FLGC $0.54
  • NEPH $2.00
  • Analyst Decision
  • FLGC Strong Buy
  • NEPH Buy
  • Analyst Count
  • FLGC 3
  • NEPH 1
  • Target Price
  • FLGC $5.00
  • NEPH $5.00
  • AVG Volume (30 Days)
  • FLGC 175.1K
  • NEPH 12.7K
  • Earning Date
  • FLGC 05-13-2025
  • NEPH 05-08-2025
  • Dividend Yield
  • FLGC N/A
  • NEPH N/A
  • EPS Growth
  • FLGC N/A
  • NEPH N/A
  • EPS
  • FLGC N/A
  • NEPH 0.01
  • Revenue
  • FLGC $59,505,000.00
  • NEPH $14,162,000.00
  • Revenue This Year
  • FLGC $4.28
  • NEPH $9.23
  • Revenue Next Year
  • FLGC N/A
  • NEPH $12.99
  • P/E Ratio
  • FLGC N/A
  • NEPH $268.85
  • Revenue Growth
  • FLGC N/A
  • NEPH N/A
  • 52 Week Low
  • FLGC $0.42
  • NEPH $1.36
  • 52 Week High
  • FLGC $2.11
  • NEPH $2.55
  • Technical
  • Relative Strength Index (RSI)
  • FLGC 44.07
  • NEPH 55.65
  • Support Level
  • FLGC $0.44
  • NEPH $1.66
  • Resistance Level
  • FLGC $0.52
  • NEPH $2.05
  • Average True Range (ATR)
  • FLGC 0.06
  • NEPH 0.11
  • MACD
  • FLGC 0.01
  • NEPH -0.00
  • Stochastic Oscillator
  • FLGC 51.75
  • NEPH 41.07

About FLGC Flora Growth Corp.

Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are; the commercial and wholesale segment (FGH and Cosechemos subsidiaries), the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries), and the pharmaceuticals segment (Grupo Farmaceutico Cronomed and Breeze Laboratory subsidiaries). Geographically, the company generates revenue from United States, Germany, and the United Kingdom. It derives a majority of its revenue from the United States.

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease.

Share on Social Networks: